Phathom Net Tangible Assets from 2010 to 2026
| PHAT Stock | USD 12.41 0.82 6.20% |
Net Tangible Assets | First Reported 2018-09-30 | Previous Quarter -90.2 M | Current Value 17.6 M | Quarterly Volatility 113.2 M |
Check Phathom Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Phathom Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 18.3 M, Depreciation And Amortization of 635.5 K or Interest Expense of 87 M, as well as many indicators such as Price To Sales Ratio of 10.14, Dividend Yield of 0.0 or Days Sales Outstanding of 280. Phathom financial statements analysis is a perfect complement when working with Phathom Pharmaceuticals Valuation or Volatility modules.
Phathom | Net Tangible Assets | Build AI portfolio with Phathom Stock |
The evolution of Net Tangible Assets for Phathom Pharmaceuticals provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Phathom Pharmaceuticals compares to historical norms and industry peers.
Latest Phathom Pharmaceuticals' Net Tangible Assets Growth Pattern
Below is the plot of the Net Tangible Assets of Phathom Pharmaceuticals over the last few years. It is the total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company. Phathom Pharmaceuticals' Net Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Phathom Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Net Tangible Assets | 10 Years Trend |
|
Net Tangible Assets |
| Timeline |
Phathom Net Tangible Assets Regression Statistics
| Arithmetic Mean | 7,474,555 | |
| Geometric Mean | 9,658,967 | |
| Coefficient Of Variation | 1,156 | |
| Mean Deviation | 55,524,510 | |
| Median | (1,286,000) | |
| Standard Deviation | 86,383,242 | |
| Sample Variance | 7462.1T | |
| Range | 302.8M | |
| R-Value | (0.18) | |
| Mean Square Error | 7713.9T | |
| R-Squared | 0.03 | |
| Significance | 0.50 | |
| Slope | (3,004,914) | |
| Total Sum of Squares | 119393T |
Phathom Net Tangible Assets History
About Phathom Pharmaceuticals Financial Statements
Phathom Pharmaceuticals shareholders use historical fundamental indicators, such as Net Tangible Assets, to determine how well the company is positioned to perform in the future. Although Phathom Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Phathom Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Phathom Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Tangible Assets | -67.3 M | -64 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Phathom Stock Analysis
When running Phathom Pharmaceuticals' price analysis, check to measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.